BGI Genomics Monthly Spotlight - October 2023

Genalive Earns CAP Accreditation to Raise the Bar for Clinical Standards in Saudi Arabia

Genalive, a leading clinical laboratory in Saudi Arabia, has passed an audit organized by the College of American Clinical Pathologists (CAP), demonstrating its excellence in clinical laboratory testing and management practices. Genalive is a joint venture between BGI Almanahil Health for Medical Services, a wholly owned subsidiary of BGI Genomics, and Tibbiyah Holding.

Click to read full article

Enhancing Prenatal Screening with Low-Pass Genome Sequencing | BGI Insight

A study led by Dr. Sun Yan, Dr. Lijie Song, Dr. Xueqin Guo from BGI Genomics and published on Journal of Medical Genetics sought to validate Low-Pass Genome Sequencing (LP GS) as an alternative to Chromosomal Microarray Analysis (CMA) for prenatal diagnosis. Additionally, it explored the critical factor of sequencing depth in LP GS, which has been a gap in previous research.

Click to read full article

Bridging the Healthcare Gap in Thailand and Beyond with the Belt and Road Initiative

On the occasion of the Belt and Road Forum for International Cooperation, Oraphan Wanacharoen, Field Application Scientist, shared her experience to facilitate technology transfer of BGI Genomics products to facilitate genetic technology applications such as non-invasive prenatal testing (NIPT).

Click to read full article

Concurrent Screening Boosts Management of Congenital Hearing Loss | BGI Insight

To understand if concurrent hearing screening and high-throughput genetic screening could improve the effectiveness of newborn hearing loss programs, a new study by Minghong Zhao, Xuemei Luo, Qinfei Zhao, Tong Yang, Wenqian Zhang (BGI Genomics, Senior Manager Clinical Research) et al. was published in the International Journal of Pediatric Otorhinolaryngology.

Click to read full article

BGI Genomics Pioneering Precision Medicine Advancements in Saudi Arabia

BGI Genomics’ Dr. Louis Luo was invited by the President of Saudi Society of Medical Genetics to participate in Saudi Society of Medical Genetics Annual Conference 2023 and delivered a speech highlighting case studies such as the world's first multi-center project of newborn genetic screening.

Click to read full article

Colombian National Cancer Institute Signs MoU with BGI Genomics to Combat Cancer

On October 2, 2023, BGI Genomics signed a Memorandum of Understanding (MoU) with the Colombian National Cancer Institute (Instituto Nacional De Cancerología E.S.E.). This collaboration, which aims to foster research and further develop cutting-edge solutions based on genetic sequencing for early diagnosis of cervical and colorectal cancer, reflects a shared dedication to enhancing health outcomes in the region.

Click to read full article

BGI Genomics Team Making Waves in Europe

BGI Genomics Europe Team?Qian(Michelle) Mao毛倩,?Jialei Zhang,?Jingyao Chen,?Peixin Chen?just wrapped up an exciting?UEG?exhibition in Copenhagen!? ? We showcased COLOTECT?, SENTIS?, Umeta, and MMHP. Our COLOTECT? self-sampling video had everyone's attention.?Thanks to our colleagues and customers for making this event a success!

Click to read full post

Don’t Miss Our Upcoming Webinar

We've got an exciting webinar coming up that you don't want to miss!? Join us on November 2nd at 7:00 am PT / 10:00 am ET as we delve into: Advancing Precision Oncology Through Genetic Panels: Comprehensive Evaluation and Patient-Centric Care.

Click to register for event